Anthony Scott Praill Kintara Therapeutics, Inc. (KTRA) insider trading activity

KTRA Quotes by TradingView

Anthony Scott Praill is Chief Financial Officer of Kintara Therapeutics, Inc.. Currently has a direct ownership of 277,273 shares of KTRA, which is worth approximately $49,909. The most recent transaction as insider was on Aug 01, 2022, when has been sold 240,087 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 277K
0% 3M change
0% 12M change
Total Value Held $49,909

Anthony Scott Praill Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 01 2022
BUY
Grant, award, or other acquisition
-
240,087 Added 46.41%
277,273 Common Stock
Dec 08 2021
BUY
Open market or private purchase
$19,516 $0.68 p/Share
28,700 Added 43.56%
37,186 Common Stock
Apr 29 2021
BUY
Conversion of derivative security
-
938 Added 9.95%
8,486 Common Stock
Apr 29 2021
BUY
Other acquisition or disposition
-
8 Added 0.11%
7,548 Common Stock
Mar 31 2021
BUY
Other acquisition or disposition
-
22 Added 0.29%
7,540 Common Stock
Dec 31 2020
BUY
Other acquisition or disposition
-
22 Added 0.29%
7,518 Common Stock
Sep 30 2020
BUY
Other acquisition or disposition
-
22 Added 0.29%
7,496 Common Stock
ASP

Anthony Scott Praill

Chief Financial Officer
San Diego, CA

Track Institutional and Insider Activities on KTRA

Follow Kintara Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KTRA shares.

Notify only if

Insider Trading

Get notified when an Kintara Therapeutics, Inc. insider buys or sells KTRA shares.

Notify only if

News

Receive news related to Kintara Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KTRA